Literature DB >> 20856129

Antiretroviral therapy use among HIV-infected men who have sex with men attending a sexually transmitted diseases clinic.

Julia C Dombrowski1, Roxanne P Kerani, Joanne D Stekler, Timothy Menza, Matthew R Golden.   

Abstract

We examined antiretroviral therapy (ART) use among 501 previously diagnosed HIV-infected men who have sex with men who sought care at a sexually transmitted disease clinic in King County, WA, during 2004-2008. Overall, 42% of men were not taking ART, 71% of whom had CD4 counts >350 cells per microliter. Of those who reported unprotected anal intercourse with a partner of nonconcordant HIV status in the prior year, 48% were not taking ART (78% with CD4 counts >350 cells/μL). Sexually transmitted disease clinics may be an important venue in which to identify persons who are not taking ART. Treating these persons could help diminish HIV transmission.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20856129      PMCID: PMC2989798          DOI: 10.1097/QAI.0b013e3181f7e2d7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  15 in total

1.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

2.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

Authors:  Reuben M Granich; Charles F Gilks; Christopher Dye; Kevin M De Cock; Brian G Williams
Journal:  Lancet       Date:  2008-11-27       Impact factor: 79.321

3.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

4.  Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis.

Authors:  Christophe Fraser; T Déirdre Hollingsworth; Ruth Chapman; Frank de Wolf; William P Hanage
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

5.  Ongoing risk behavior among persons with HIV in medical care.

Authors:  Matthew R Golden; Robert W Wood; Susan E Buskin; Mark Fleming; Robert D Harrington
Journal:  AIDS Behav       Date:  2007-05-12

6.  HIV serosorting in men who have sex with men: is it safe?

Authors:  Matthew R Golden; Joanne Stekler; James P Hughes; Robert W Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

7.  Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.

Authors:  Viviane D Lima; Karissa Johnston; Robert S Hogg; Adrian R Levy; P Richard Harrigan; Aranka Anema; Julio S G Montaner
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

8.  Effect of early versus deferred antiretroviral therapy for HIV on survival.

Authors:  Mari M Kitahata; Stephen J Gange; Alison G Abraham; Barry Merriman; Michael S Saag; Amy C Justice; Robert S Hogg; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore
Journal:  N Engl J Med       Date:  2009-04-01       Impact factor: 91.245

9.  Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005.

Authors:  Patrick S Sullivan; Osamah Hamouda; Valerie Delpech; Jennifer E Geduld; Joseph Prejean; Caroline Semaille; John Kaldor; Cinta Folch; Eline Op de Coul; Ulrich Marcus; Gwenda Hughes; Chris P Archibald; Francoise Cazein; Ann McDonald; Jordi Casabona; Ard van Sighem; Kevin A Fenton
Journal:  Ann Epidemiol       Date:  2009-06       Impact factor: 3.797

Review 10.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321

View more
  3 in total

Review 1.  Understanding structural barriers to accessing HIV testing and prevention services among black men who have sex with men (BMSM) in the United States.

Authors:  Matthew E Levy; Leo Wilton; Gregory Phillips; Sara Nelson Glick; Irene Kuo; Russell A Brewer; Ayana Elliott; Christopher Watson; Manya Magnus
Journal:  AIDS Behav       Date:  2014-05

2.  Understanding disparities in viral suppression among Black MSM living with HIV in Atlanta Georgia.

Authors:  Patrick S Sullivan; Justin Knox; Jeb Jones; Jennifer Taussig; Mariah Valentine Graves; Greg Millett; Nicole Luisi; Eric Hall; Travis H Sanchez; Carlos Del Rio; Colleen Kelley; Eli S Rosenberg; Jodie L Guest
Journal:  J Int AIDS Soc       Date:  2021-04       Impact factor: 5.396

3.  Disparities in HIV transmission risk among HIV-infected black and white men who have sex with men, United States, 2009.

Authors:  Linda Beer; Alexandra M Oster; Christine L Mattson; Jacek Skarbinski
Journal:  AIDS       Date:  2014-01-02       Impact factor: 4.177

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.